Sissi V. Pham

1.0k total citations
30 papers, 728 citations indexed

About

Sissi V. Pham is a scholar working on Infectious Diseases, Epidemiology and Physiology. According to data from OpenAlex, Sissi V. Pham has authored 30 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Sissi V. Pham's work include HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Sissi V. Pham is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Sissi V. Pham collaborates with scholars based in United States, Australia and United Kingdom. Sissi V. Pham's co-authors include JoLaine R. Draugalis, Edward P. Armstrong, Daniel C. Malone, Robert H. Dworkin, Denise Kruzikas, Didier Allexandre, Mitchell K. Higashi, Emily Fox, Pat Ray Reese and Alex Z. Fu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Stroke.

In The Last Decade

Sissi V. Pham

28 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sissi V. Pham United States 15 195 161 152 120 99 30 728
Ian Kudel United States 19 221 1.1× 116 0.7× 77 0.5× 179 1.5× 125 1.3× 37 1.0k
Melissa A. Elafros United States 15 157 0.8× 128 0.8× 161 1.1× 95 0.8× 118 1.2× 43 850
Sharon Pipkin United States 16 68 0.3× 81 0.5× 220 1.4× 108 0.9× 285 2.9× 29 1.4k
Fiona Duncan United Kingdom 19 121 0.6× 204 1.3× 133 0.9× 52 0.4× 795 8.0× 44 1.4k
Sermsak Lolak United States 12 52 0.3× 74 0.5× 51 0.3× 76 0.6× 127 1.3× 18 791
Nicholas Hartman United States 15 119 0.6× 62 0.4× 127 0.8× 78 0.7× 106 1.1× 56 960
Emmanouil Bagkeris United Kingdom 18 69 0.4× 65 0.4× 174 1.1× 34 0.3× 174 1.8× 45 790
Matthew Wright United States 18 40 0.2× 159 1.0× 161 1.1× 48 0.4× 306 3.1× 37 859
Anupama Kalsekar United States 18 58 0.3× 228 1.4× 104 0.7× 104 0.9× 250 2.5× 55 1.5k
Michael Wood Japan 6 681 3.5× 116 0.7× 95 0.6× 17 0.1× 80 0.8× 14 1.2k

Countries citing papers authored by Sissi V. Pham

Since Specialization
Citations

This map shows the geographic impact of Sissi V. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sissi V. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sissi V. Pham more than expected).

Fields of papers citing papers by Sissi V. Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sissi V. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sissi V. Pham. The network helps show where Sissi V. Pham may publish in the future.

Co-authorship network of co-authors of Sissi V. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Sissi V. Pham. A scholar is included among the top collaborators of Sissi V. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sissi V. Pham. Sissi V. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Armstrong, Edward P., Duska M. Franic, Daniel C. Malone, et al.. (2024). Patient-centric care in myelodysplastic syndromes: A global systematic literature review and gap analysis. Leukemia Research. 147. 107592–107592.
2.
Garey, Kevin W., Anne J Gonzales-Luna, Brittany Lapin, et al.. (2023). Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109. JAMA Network Open. 6(1). e2253570–e2253570. 20 indexed citations
3.
Armstrong, Edward P., et al.. (2023). Patient Experiences with Clostridioides difficile Infection and Its Treatment: A Systematic Literature Review. Infectious Diseases and Therapy. 12(7). 1775–1795. 2 indexed citations
4.
Cohen, Stuart H., Thomas Louie, Charles S. Berenson, et al.. (2022). Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection. SHILAP Revista de lepidopterología. 2(S1). s73–s73. 2 indexed citations
5.
6.
Kruzikas, Denise, et al.. (2020). HTA and economics in the United States: a systematic review of ICER reports to evaluate trends, identify factors associated with recommendations, and understand implications. Journal of Managed Care & Specialty Pharmacy. 26(12). 1548–1557. 2 indexed citations
7.
Allexandre, Didier, Emily Fox, Alex Z. Fu, et al.. (2013). Feasibility of an Online Mindfulness Program for Stress Management—A Randomized, Controlled Trial. Annals of Behavioral Medicine. 46(2). 137–148. 121 indexed citations
8.
Rymer, Marilyn M., et al.. (2013). Analysis of the Costs and Payments of a Coordinated Stroke Center and Regional Stroke Network. Stroke. 44(8). 2254–2259. 5 indexed citations
9.
Dworkin, Robert H., et al.. (2012). Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations?. Pain. 153(4). 869–875. 29 indexed citations
10.
Dworkin, Robert H., et al.. (2011). Healthcare Utilization in People with Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy. Journal of the American Geriatrics Society. 59(5). 827–836. 28 indexed citations
11.
Stang, Paul, et al.. (2008). The Identification of Benefit in Medical Intervention: An Overview and Suggestions for Process. American Journal of Therapeutics. 15(5). 495–503. 5 indexed citations
12.
Chen, Ray Y., Andrew O. Westfall, James L. Raper, et al.. (2002). Immunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical Practice. AIDS Research and Human Retroviruses. 18(13). 909–916. 18 indexed citations
13.
Ross, Lisa, Qiming Liao, Haitao Gao, et al.. (2001). Impact of HIV Type 1 Drug Resistance Mutations and Phenotypic Resistance Profile on Virologic Response to Salvage Therapy. AIDS Research and Human Retroviruses. 17(15). 1379–1385. 12 indexed citations
14.
Call, Stephanie, Michael S. Saag, Andrew O. Westfall, et al.. (2001). Phenotypic Drug Susceptibility Testing Predicts Long‐Term Virologic Suppression Better than Treatment History in Patients with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 183(3). 401–408. 21 indexed citations
15.
Mauskopf, Josephine, Jerry M. Tolson, Kit N. Simpson, Sissi V. Pham, & James T. Albright. (2000). Impact of Zidovudine-Based Triple Combination Therapy on an AIDS Drug Assistance Program. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(4). 302–313. 1 indexed citations
16.
Lacey, L.F., Josephine Mauskopf, Richard C. Lindrooth, et al.. (1999). A Prospective Cost-Consequence Analysis of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens for HIV Infection in the US. PharmacoEconomics. 15(Supplement 1). 23–37. 14 indexed citations
17.
Stewart, Kirsten, Patricia G. Greene, Stephanie Call, et al.. (1998). Patterns of self-reported adherence to ART in a prospective clinical cohort. 38. 420–421. 6 indexed citations
18.
Bouchard, Josée, Pietro Cortelli, C Dahlöf, et al.. (1997). A Multinational Investigation of the Impact of Subcutaneous Sumatriptan. PharmacoEconomics. 11(Supplement 1). 43–50. 26 indexed citations
19.
Dahlöf, C, Josée Bouchard, Pietro Cortelli, et al.. (1997). A Multinational Investigation of the Impact of Subcutaneous Sumatriptan. PharmacoEconomics. 11(Supplement 1). 24–34. 38 indexed citations
20.
Pham, Sissi V. & JoLaine R. Draugalis. (1993). Quality of life 2. Pharmacy World & Science. 15(2). 50–55. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026